Vagus nerve stimulation reduces cocaine seeking and alters plasticity in the extinction network

Learning and Memory

Volumn 24, Issue 1, 2017, Pages 35-42

  Childs, Jessica E ^a   DeLeon, Jaime ^a   Nickel, Emily ^a   Kroener, Sven ^a  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; COCAINE; CYCLIC AMP; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR CAMP RESPONSE ELEMENT BINDING PROTEIN; UNCLASSIFIED DRUG; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; LOCAL ANESTHETIC AGENT;

AMYGDALA; APPETITE; ARTICLE; ASSOCIATION; BASOLATERAL AMYGDALA; CONTROLLED STUDY; ELECTRIC POTENTIAL; EVOKED RESPONSE; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; LEARNING; NERVE CELL PLASTICITY; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; RELAPSE; VAGUS NERVE STIMULATION; ANALYSIS OF VARIANCE; ANIMAL; APPETITIVE BEHAVIOR; BRAIN; DRUG EFFECTS; DRUG SEEKING BEHAVIOR; DRUG SELF ADMINISTRATION; FOOD; INSTRUMENTAL CONDITIONING; MALE; METABOLISM; PHYSIOLOGY; REINFORCEMENT; SPRAGUE DAWLEY RAT;

ANALYSIS OF VARIANCE; ANESTHETICS, LOCAL; ANIMALS; APPETITIVE BEHAVIOR; BRAIN; COCAINE; CONDITIONING, OPERANT; CREB-BINDING PROTEIN; DRUG-SEEKING BEHAVIOR; EXTINCTION, PSYCHOLOGICAL; FOOD; MALE; NEURONAL PLASTICITY; RATS; RATS, SPRAGUE-DAWLEY; SELF ADMINISTRATION; VAGUS NERVE STIMULATION;

EID: 85010408552     PISSN: 10720502     EISSN: 15495485     Source Type: Journal    
DOI: 10.1101/lm.043539.116     Document Type: Article

References (55)

1. Aihua L, Lu S, Liping L, XiuruW, Hua L, YupingW. 2014. A controlled trial of transcutaneous vagus nerve stimulation for the treatment of pharmacoresistant epilepsy. Epilepsy Behav 39: 105-110.
2. Chase HM, Sterman MB, Clemente CD. 1966. Cortical and subcortical patters of response to afferent vagal stimulation. Exp Neurol 16: 36-49.
3. Childs JE, Alvaraz-Dieppa A, McIntyre C, Kroener S. 2015. Vagus nerve stimulation as a tool to induce plasticity in pathways relevant for extinction learning. J Vis Exp 102: e53032.
4. Clark KB, Krahl SE, Smith DC, Jensen RA. 1995. Post-training unilateral vagal stimulation enhances retention performance in the rat. Neurobiol Learn Mem 63: 213-216.
5. Conklin CA, Tiffany ST. 2002. Applying extinction research and theory to cue-exposure addiction treatments. Addiction 97: 155-167.
6. Dutra L, Stathopoulou G, Badsen SL, Leyro TM, Powers MB, Otto MW. 2008. A meta-analytic review of psychosocial interventions for substance use disorders. Am J Psychiatry 165: 179-187.
7. Elliott RE, Morsi A, Kalhorn SP, Marcus J, Sellin J, Kang M, Silverberg A, Rivera E, Geller E, Carlson C, et al. 2011. Vagus nerve stimulation in 436 consecutive patients with treatment resistant epilepsy: long-term outcomes and predictors of response. Epilepsy Behav 20: 57-63.
8. Engineer ND, Riley JR, Seale JD, Vrana WA, Shetake JA, Sudanagunta SP, Borland MS, Kilgard MP. 2011. Reversing pathological neural activity using targeted plasticity. Nature 470: 101-104.
9. Ettenberg A, Pettit HO, Bloom FE, Koob GF. 1982. Heroin and cocaine intravenous self-administration in rats: mediation by separate neural systems. Psychopharmacology 78: 204-209.
10. Fowler JS, Volkow ND, Kassed CA, Chang L. 2007. Imaging the addicted human brain. Sci Pract Perspect 3: 4-16.
11. Handforth A, DeGiorgio CM, Schachter SC, Uthman BM, Naritoku DK, Tecoma ES, Henry TR, Collins SD, Vaughn BV, Gilmartin RC, et al. 1998. Vagus nerve stimulation therapy for partial onset seizures: a randomized active-control trial. Neurology 51: 48-55.
12. Hassert DL, Miyashita T,Williams CL. 2004. The effects of peripheral vagal nerve stimulation at a memory-modulating intensity of norepinephrine output in the basolateral amygdala. Behav Neurosci 118: 79-88.
13. Hays SA, Rennaker RL, Kilgard MP. 2013. Targeting plasticity with vagus nerve stimulation to treat neurological disease. Prog Brain Res 207: 275-299.
14. Hays SA, Khodaparast N, Hulsey DR, Ruiz A, Sloan AM, Rennaker RL, Kilgard MP. 2014a. Vagus nerve stimulation during rehabilitative training improves functional recovery after intracerebral hemorrhage. Stroke 45: 3097-3100.
15. Hays SA, Khodaparast N, Ruiz A, Sloan AM, Hulsey DR, Rennaker RL, Kilgard MP. 2014b. The timing and amount of vagus nerve stimulation during rehabilitative training affect poststroke recovery of forelimb strength. Neuroreport 25: 676-682.
16. Jentsch JD, Taylor JR. 1999. Impulsivity resulting from frontostriatal dysfunction in drug abuse: implications for the control of behavior by reward-related stimuli. Psychopharmacology 146: 373-390.
17. Kantak KM, Nic Dhonnchadha BÁ. 2011. Pharmacological enhancement of drug cue extinction learning: translational challenges. Ann N Y Acad Sci 1216: 122-137.
18. Kilgard MP. 2012. Harnessing plasticity to understand learning and treat disease. Trends Neurosci 35: 715-722.
19. Knackstedt LA, Moussawi K, Lalumiere R, Schwendt M, Klugmann M, Kalivas PW. 2010. Extinction training after cocaine self-administration induces glutamatergic plasticity to inhibit cocaine seeking. J Neurosci 30: 7984-7992.
20. Krahl SE, Clark KB. 2012. Vagus nerve stimulation for epilepsy: a review of central mechanisms. Surg Neurol Int 3: 255-259.
21. Kruzich PJ, See RE. 2001. Differential contributions of the basolateral and central amygdala in the acquisition and expression of conditioned relapse to cocaine-seeking behavior. J Neurosci 21: RC155.
22. Liu J, Liang J, QinW, Tian J, Yuan K, Bai L, Zhang Y,WangW,Wang Y, Li Q, et al. 2009. Dysfunctional connectivity patterns in chronic heroin users: an fMRI study. Neurosci Lett 460: 72-77.
23. Liu H, Liu Y, Yu J, Lai M, Zhu H, Sun A, Chen W, Zhou W. 2011. Vagus nerve stimulation inhibits heroin-seeking behavior induced by heroin priming or heroin-associated cues in rats. Neurosci Lett 494: 70-74.
24. Manta S, Dong J, Debonnel G, Blier P. 2009. Enhancement of the function of rat serotonin and norepinephrine neurons by sustained vagus nerve stimulation. J Psychiatry Neurosci 34: 372-280.
25. McFarland K, Kalivas PW. 2001. The circuitry mediating cocaine-induced reinstatement of drug-seeking behavior. J Neurosci 21 8655-8663
26. McLaughlin J, See RE. 2003. Selective inactivation of the dorsomedial prefrontal cortex and the basolateral amygdala attenuates conditioned-cued reinstatement of extinguished cocaine-seeking behavior in rats. Psychopharmacology (Berl) 168: 57-65.
27. Millan ZE, Marchant NJ, McNally GP. 2011. Extinction of drug seeking. Behav Brain Res 271: 454-462.
28. Moorman DE, Aston-Jones G. 2014. Orbitofrontal cortical neurons encode expectation-driven initiation of reward-seeking. J Neurosci 34: 10234-10246.
29. Moorman DE, Jame MH, McGlinchey EM, Aston-Jones G. 2015. Differential roles of medial prefrontal subregions in the regulation of drug seeking. Brain Res 1628: 130-146.
30. Moussawi K, Pacchioni A, Moran M, Olive MF, Grass JT, Lavin A, Kalivas PW. 2009. N-Acetylcysteine reverses cocaine-induced metaplasticity. Nat Neurosci 12: 182-189.
31. Moussawi K, Zhou W, Shen H, Reichel CM, See RE, Carr DB, Kalivas PW. 2011. Reversing cocaine-induced synaptic potentiation provides enduring protection from relapse. Proc Natl Acad Sci 108: 385-390.
32. Naritoku DK, Terry WJ, Helfer RH. 1995. Regional induction of fos immunoreactivity in the brain by anticonvulsant stimulation of the vagus nerve. Epilepsy Res 22: 53-62.
33. Nestler EJ. 2009. Cellular and molecular mechanisms of drug addiction. In Neurobiology of Mental Illness (ed. DS Charney, EJ Nestler) pp. 775-785. Oxford University Press, New York.
34. Nic Dhonnchadha BÁ, Cunningham KA. 2008. Serotonergic mechanisms in addiction-related memories. Behav Brain Res 195: 39-53.
35. Nic Dhonnchadha BÁ, Kantak KM. 2011. Cognitive enhancers for facilitating drug cue extinction: insights from animal models. Pharmacol Biochem Behav 99 229-244
36. Peña DF, Engineer ND, McIntyre CK. 2013. Rapid remission of conditioned fear expression with extinction training paired with vagus nerve stimulation. Biol Psychiatry 73: 1071-1077.
37. Peña DF, Childs JE, Willet SM, Vital A, McIntyre CK, Kroener S. 2014. Vagus nerve stimulation enhances extinction of conditioned fear and modulates plasticity in the pathway from the ventromedial prefrontal cortex to the amygdala. Front Behav Neurosci 8: 327.
38. Peters J, LaLumiere RT, Kalivas PW. 2008. Infralimbic prefrontal cortex is responsible for inhibiting cocaine seeking in extinguished rats. J Neurosci 28: 6046-6053.
39. Peters J, Kalivas PW, Quirk GJ. 2009. Extinction circuits for fear and addiction overlap in prefrontal cortex. Learn Mem 16: 279-288.
40. Peters J, Pattij T, De Vries TJ. 2013. Targeting cocaine versus heroin memories: divergent roles within ventromedial prefrontal cortex. Trends Pharmacol Sci 34: 689-695.
41. Porter BA, Khodaparast N, Fayyaz T, Cheung RJ, Ahmed SS, Vrana WA, Rennaker RL II, Kilgard MP. 2012. Repeatedly pairing vagus nerve stimulation with a movement reorganizes primary motor cortex. Cereb Cortex 22: 2365-2374.
42. Quirk GJ, Mueller D. 2008. Neural mechanisms of extinction learning and retrieval. Neuropsychopharmacology 33: 56-72.
43. Rogers JL, Ghee S, See RE. 2008. The neural circuitry underlying reinstatement of heroin-seeking behavior in an animal model of relapse. Neuroscience 151: 579-588.
44. Rush AJ, George MS, Sackeim HA, Marangell LB, Husain MM, Giller C. 2000. Vagus nerve stimulation (VNS) for treatment-resistant depression: a multicenter study. Biol Psychiatry 47: 276-286.
45. Sackheim HA, Rush AJ, George MS, Marangell LB, Husain MM, Nahas Z. 2001. Vagus nerve stimulation (VNS) for treatment-resistant depression: efficacy, side effects, and predictors of outcome. Neuropsychopharmacology 25: 713-728.
46. See RE. 2005. Neural substrates of cocaine-cue associations that trigger relapse. Eur J Pharmacol 526: 140-146.
47. Self DW, Choi K, Simmons D, Walker JR, Smagula CS. 2004. Extinction training regulates neuroadaptive responses to withdrawal from chronic cocaine self-administration. Learn Mem 11: 648-657.
48. Sierra-Mercado D, Padilla-Coreano N, Quirk GJ. 2011. Dissociable roles of prelimbic and infralimbic cortices, ventral hippocampus and basolateral amygdala in the expression and extinction of conditioned fear. Neuropsychopharmacology 36: 529-538.
49. Sinha R, Li CS. 2007. Imaging stress- and cue-induced drug and alcohol craving: association with relapse and clinical implications. Drug Alcohol Rev 26: 25-31.
50. Taylor JR, Olausson P, Quinn JJ, Torregrossa MM. 2009. Targeting extinction and reconsolidation mechanisms to combat the impact of drug cues on addiction. Neuropharmacology 56: 186-195.
51. Vouimba RM, Maroun M. 2011. Learning-induced changes in mPFC-BLA connections after fear conditioning, extinction and reinstatement of fear. Neuropsychopharmacology 36: 2276-2285.
52. Weiss F, Martin-Fardon R, Ciccocioppo R, Kerr TM, Smith DL, Ben-Shahar O. 2001. Enduring resistance to extinction of cocaine-seeking behavior induced by drug-related cues. Neuropsychopharmacology 25: 361-372.
53. Weissenborn R, Robbins TW, Everitt BJ. 1997. Effects of medial prefrontal or anterior cingulate cortex lesions on responding for cocaine under fixed-ratio and second-order schedules of reinforcement in rats. Psychopharmacology (Berl) 134: 242-257.
54. Zhou LF, Zhu YP. 2006. Changes of CREB in rat hippocampus, prefrontal cortex and nucleus accumbens during three phases of morphine induced conditioned place preference in rats. J Zhejiang Univ Sci B 7: 107-113.
55. Zuo Y, Smith DC, Jensen RA. 2007. Vagus nerve stimulation potentiates hippocampal LTP in freely moving rats. Physiol Behav 90: 583-589.